These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18499163)

  • 1. Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA damaging chemotherapy associated with enhancement of phospho-p53.
    Park SH; Park JY; Weiss RH
    J Urol; 2008 Jul; 180(1):352-60. PubMed ID: 18499163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers.
    Park SH; Wang X; Liu R; Lam KS; Weiss RH
    Cancer Biol Ther; 2008 Dec; 7(12):2015-22. PubMed ID: 18981726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of cyclin dependent kinases causes p53 dependent apoptosis in renal cell carcinoma.
    Ishimaru T; Lau J; Jackson AL; Modiano JF; Weiss RH
    J Urol; 2010 Nov; 184(5):2143-9. PubMed ID: 20850841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.
    Inoue H; Hwang SH; Wecksler AT; Hammock BD; Weiss RH
    Cancer Biol Ther; 2011 Nov; 12(9):827-36. PubMed ID: 21878748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.
    Lin PY; Fosmire SP; Park SH; Park JY; Baksh S; Modiano JF; Weiss RH
    Mol Cancer; 2007 Feb; 6():16. PubMed ID: 17300726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.
    Kralj M; Pavelić J
    J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
    Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.
    Kim JH; Chae M; Kim WK; Kim YJ; Kang HS; Kim HS; Yoon S
    Br J Pharmacol; 2011 Feb; 162(3):773-84. PubMed ID: 20973777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
    Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
    Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells.
    Fan Y; Borowsky AD; Weiss RH
    Mol Cancer Ther; 2003 Aug; 2(8):773-82. PubMed ID: 12939467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
    Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent.
    di Pietro A; Koster R; Boersma-van Eck W; Dam WA; Mulder NH; Gietema JA; de Vries EG; de Jong S
    Cell Cycle; 2012 Dec; 11(24):4552-62. PubMed ID: 23165211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.
    Qiu M; Ke L; Zhang S; Zeng X; Fang Z; Liu J
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):275-286. PubMed ID: 28608259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M; Roemer K
    Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
    Kang JH; Lee JS; Hong D; Lee SH; Kim N; Lee WK; Sung TW; Gong YD; Kim SY
    Cell Death Dis; 2016 Mar; 7(3):e2163. PubMed ID: 27031960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diosmetin Induces Apoptosis by Downregulating AKT Phosphorylation via P53 Activation in Human Renal Carcinoma ACHN Cells.
    Qiu M; Liu J; Su Y; Guo R; Zhao B; Liu J
    Protein Pept Lett; 2020; 27(10):1022-1028. PubMed ID: 32223728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells.
    Simões Magluta EP; Vasconcelos FC; Maia RC; Klumb CE
    Cancer Invest; 2009 Oct; 27(8):830-5. PubMed ID: 19557576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma.
    Zhang Q; Shi J; Yuan F; Wang H; Fu W; Pan J; Huang Y; Yu J; Yang J; Chen Z
    Int J Cancer; 2016 Dec; 139(12):2827-2837. PubMed ID: 27542841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.